About
Basic Data Updated:
4 months agoGLS Pharma Limited, a renowned pharmaceutical company, specializes in cancer chemotherapy and chemo supportive drugs for patients suffering from various types of malignancies. In addition to this, the company also offers medicines for gynecology, phytopharmaceuticals (under its new division Giovell), and general pharma. These products are supplied to numerous hospitals and medical colleges, including Adyar Cancer Institute in Chennai, Apollo Hospital Cancer Centre in Chennai, Delhi, and Hyderabad, Kidwai Cancer Institute in Bangalore, Regional Cancer Centre Hospital in Trivandrum, Tata Memorial Hospital in Mumbai, Hinduja Hospital in Mumbai, and Jawaharlal Nehru Cancer Hospital & Research Centre in Bhopal, among others. Headquartered in New Delhi, GLS Pharma Limited has a central warehouse and 18 branch offices spread across the country. Its state-of-the-art manufacturing unit is located in Jeedimetla Industrial Estate, Hyderabad. The company takes pride in its high-quality products and is committed to providing effective and affordable healthcare solutions to patients in need. With a team of dedicated professionals and a strong distribution network, GLS Pharma Limited continues to make a significant impact in the pharmaceutical industry.
Industry
Company Details
- Location
South Delhi, Delhi, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24239DL2004PLC128728 |
| Company No. | 128728 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 01 Sep 2004 |
| Date of AGM | 25 Aug 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Delhi |
Products or Services related to Gls Pharma Limited
Arthritic Drugs
Anti Cancer Medicines
Anti Cancer Injection
VTM Kit Raw Materials
Financials of Gls Pharma Limited
Gls Pharma Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 1.69% increase. The company also saw a slight decrease in profitability, with a 3.23% decrease in profit. The company's net worth Soared by an impressive increase of 32.22%.
Corporate Structure
Unlock access to Gls Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Gls Pharma Limited
Unlock and access historical data on people associated with Gls Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
Suresh Pathak
Managing DirectorAppointment Date: 01-Sep-2004
Status: Current
Board Members(4)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 20 Sep 2022 | ₹7.00 Cr | Open |
Icici Bank Limited Creation Date: 11 Jan 2007 | ₹8.00 M | Open |
Canara Bank Creation Date: 30 Aug 2021 | ₹2.50 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gls Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gls Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
30 years 6 months 
Recent activity within the organization
Annual General Meeting
Gls Pharma Limited last Annual general meeting of members was held on 25 Aug 2023 as per latest MCA records.
25 Aug 2023Balance Sheet
Gls Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
31 Mar 2023Charges
A charge registered on 30 Aug 2021 via Charge ID 100492779 with Canara Bank was fully satisfied on 24 Sep 2022.
24 Sep 2022Charges
A charge registered on 15 Dec 2020 via Charge ID 100411450 with Syndicate Bank was fully satisfied on 24 Sep 2022.
24 Sep 2022Charges
A charge registered on 14 Dec 2020 via Charge ID 100411449 with Canara Bank was fully satisfied on 24 Sep 2022.
24 Sep 2022
Frequently asked questions
What is the Incorporation or founding date of Gls Pharma Limited?
